VC Catalog · venture ecosystem research library
VC Catalog home Beta

VC firm

Curie Capital

Kingmaker TierBased on the data VC Catalog holds.

Kingmaker Tier: 81 out of 100

  • Biotech & therapeutics
  • Medical devices & diagnostics
  • Seed
  • Series A
  • NL
  • VC
Investor type
VC
Investing status
Activeas of 2026-09-22Source (opens in a new tab)
Headquarters
Amsterdam, MA, The Netherlands
Founded
2018
Legal name
Curie Capital B.V.
Claim, correct or request removal

Record updated 27 September 2026

About

Curie Capital, founded in 2018 and headquartered in Amsterdam, is a Life Sciences focused venture capital firm specialized in investing in early-stage companies. We have the experience, risk appetite and funds to invest in talented teams with exciting new medical products. We syndicate with experienced co-investors and support portfolio companies with our broad experiences in various areas and access to our extensive network. Curie Capital brings more to the table than capital; we actually help you to build your company.

Investment approach

Thesis
Our mission and vision is to bring new scientific technologies to the benefit of patients worldwide. Marie Curie’s relentless devotion and insatiable curiosity made her an icon in science, and a two-time Nobel Prize winner. Through her physically demanding and unfortunately fatal work, she discovered polonium, radium and championed the practical use of radiation, which led to products like first generation radiopharmaceuticals and x-ray machines. In the same spirit of innovating healthcare, Curie Capital wants to have a meaningful impact on patients’ lives. Our strategy is to make smart investments in high potential early-stage Biotechnology and Medical technology companies. Within the Life Sciences sector we search for first- or best-inSource (opens in a new tab)
Eligibility
From our current fund (Curie Capital 3), we are compliant with the RVO seed capital regulations and therefore invest only in companies that have a Dutch headquarters and that have, so far, not raised more than €3,5 million in equity and/or convertible loan agreements.
Investing status notes
We invest in Seed and Series A stage Biotechnology, Pharmaceutical and Medical Technology companies, typically focused on therapeutics, diagnostics or class IIb and III medical devices.

Locations

Office
Amstelveen, The Netherlands
Loading relationship preview

Cookies on VC Catalog

We use necessary cookies to run the site (sign-in, security, remembering this choice). With your permission we also use Google Analytics to understand how the site is used. Analytics cookies are set only if you accept all cookies. Privacy policy